GO:0003747 | translation release factor activity | 5.79e-06 | 5.65e-02 | 8.668 | 2 | 2 | 2 |
GO:0000398 | mRNA splicing, via spliceosome | 1.25e-05 | 1.22e-01 | 3.990 | 5 | 15 | 128 |
GO:0003723 | RNA binding | 2.26e-05 | 2.21e-01 | 3.305 | 6 | 22 | 247 |
GO:0008380 | RNA splicing | 4.25e-05 | 4.15e-01 | 3.624 | 5 | 21 | 165 |
GO:0031124 | mRNA 3'-end processing | 8.11e-05 | 7.92e-01 | 5.124 | 3 | 4 | 35 |
GO:0006369 | termination of RNA polymerase II transcription | 1.04e-04 | 1.00e+00 | 5.005 | 3 | 5 | 38 |
GO:0006379 | mRNA cleavage | 2.06e-04 | 1.00e+00 | 6.499 | 2 | 2 | 9 |
GO:0010467 | gene expression | 2.18e-04 | 1.00e+00 | 2.412 | 7 | 49 | 535 |
GO:0006479 | protein methylation | 3.14e-04 | 1.00e+00 | 6.209 | 2 | 2 | 11 |
GO:0005654 | nucleoplasm | 8.11e-04 | 1.00e+00 | 1.894 | 8 | 68 | 876 |
GO:0030529 | ribonucleoprotein complex | 1.02e-03 | 1.00e+00 | 3.896 | 3 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.09e-03 | 1.00e+00 | 3.861 | 3 | 5 | 84 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.55e-03 | 1.00e+00 | 5.083 | 2 | 5 | 24 |
GO:0004832 | valine-tRNA ligase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0080129 | proteasome core complex assembly | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0016300 | tRNA (uracil) methyltransferase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 1 |
GO:0050434 | positive regulation of viral transcription | 3.28e-03 | 1.00e+00 | 4.539 | 2 | 5 | 35 |
GO:0000775 | chromosome, centromeric region | 4.48e-03 | 1.00e+00 | 4.311 | 2 | 6 | 41 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0034969 | histone arginine methylation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 2 |
GO:0006406 | mRNA export from nucleus | 5.14e-03 | 1.00e+00 | 4.209 | 2 | 7 | 44 |
GO:0005829 | cytosol | 6.62e-03 | 1.00e+00 | 1.187 | 10 | 88 | 1787 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.12e-03 | 1.00e+00 | 3.968 | 2 | 8 | 52 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 2 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0002098 | tRNA wobble uridine modification | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0006563 | L-serine metabolic process | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0016274 | protein-arginine N-methyltransferase activity | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0008469 | histone-arginine N-methyltransferase activity | 7.36e-03 | 1.00e+00 | 7.083 | 1 | 1 | 3 |
GO:0006366 | transcription from RNA polymerase II promoter | 8.93e-03 | 1.00e+00 | 2.255 | 4 | 23 | 341 |
GO:0021930 | cerebellar granule cell precursor proliferation | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0043248 | proteasome assembly | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 4 |
GO:0004652 | polynucleotide adenylyltransferase activity | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 2 | 4 |
GO:0043631 | RNA polyadenylation | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0072341 | modified amino acid binding | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0006564 | L-serine biosynthetic process | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine | 9.80e-03 | 1.00e+00 | 6.668 | 1 | 1 | 4 |
GO:0006415 | translational termination | 1.03e-02 | 1.00e+00 | 3.691 | 2 | 2 | 63 |
GO:0004521 | endoribonuclease activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:0006282 | regulation of DNA repair | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 5 |
GO:0001649 | osteoblast differentiation | 1.40e-02 | 1.00e+00 | 3.459 | 2 | 5 | 74 |
GO:0050847 | progesterone receptor signaling pathway | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 4 | 7 |
GO:0005845 | mRNA cap binding complex | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0070628 | proteasome binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 4 | 8 |
GO:0005739 | mitochondrion | 2.00e-02 | 1.00e+00 | 1.626 | 5 | 32 | 659 |
GO:0010225 | response to UV-C | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:0030488 | tRNA methylation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 2 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 3 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 11 |
GO:0005666 | DNA-directed RNA polymerase III complex | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 3 | 13 |
GO:0000287 | magnesium ion binding | 3.21e-02 | 1.00e+00 | 2.823 | 2 | 4 | 115 |
GO:0006386 | termination of RNA polymerase III transcription | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 2 | 14 |
GO:0005737 | cytoplasm | 3.63e-02 | 1.00e+00 | 0.765 | 11 | 127 | 2633 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 4 | 15 |
GO:0005515 | protein binding | 3.63e-02 | 1.00e+00 | 0.566 | 15 | 198 | 4124 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 2 | 16 |
GO:0005782 | peroxisomal matrix | 3.86e-02 | 1.00e+00 | 4.668 | 1 | 1 | 16 |
GO:0043022 | ribosome binding | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 2 | 17 |
GO:0031667 | response to nutrient levels | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 2 | 17 |
GO:0044822 | poly(A) RNA binding | 4.17e-02 | 1.00e+00 | 1.348 | 5 | 45 | 799 |
GO:0003899 | DNA-directed RNA polymerase activity | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 18 |
GO:0031047 | gene silencing by RNA | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 18 |
GO:0033574 | response to testosterone | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 1 | 18 |
GO:0031397 | negative regulation of protein ubiquitination | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 18 |
GO:0006913 | nucleocytoplasmic transport | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0071346 | cellular response to interferon-gamma | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 1 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 5.04e-02 | 1.00e+00 | 4.276 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 1 | 22 |
GO:0044267 | cellular protein metabolic process | 5.37e-02 | 1.00e+00 | 1.794 | 3 | 14 | 352 |
GO:0000049 | tRNA binding | 5.51e-02 | 1.00e+00 | 4.145 | 1 | 2 | 23 |
GO:0008180 | COP9 signalosome | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 6 | 24 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 25 |
GO:0030145 | manganese ion binding | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 26 |
GO:0009267 | cellular response to starvation | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 1 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 4 | 27 |
GO:0016071 | mRNA metabolic process | 6.48e-02 | 1.00e+00 | 2.259 | 2 | 10 | 170 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 6 | 29 |
GO:0005778 | peroxisomal membrane | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 3 | 29 |
GO:0006446 | regulation of translational initiation | 6.90e-02 | 1.00e+00 | 3.810 | 1 | 2 | 29 |
GO:0006412 | translation | 7.02e-02 | 1.00e+00 | 2.193 | 2 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 7.09e-02 | 1.00e+00 | 2.185 | 2 | 17 | 179 |
GO:0008168 | methyltransferase activity | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 2 | 30 |
GO:0045111 | intermediate filament cytoskeleton | 7.36e-02 | 1.00e+00 | 3.714 | 1 | 3 | 31 |
GO:0016070 | RNA metabolic process | 7.72e-02 | 1.00e+00 | 2.114 | 2 | 10 | 188 |
GO:0017148 | negative regulation of translation | 7.81e-02 | 1.00e+00 | 3.624 | 1 | 5 | 33 |
GO:0007254 | JNK cascade | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 1 | 34 |
GO:0044297 | cell body | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 5 | 35 |
GO:0016032 | viral process | 8.57e-02 | 1.00e+00 | 1.512 | 3 | 30 | 428 |
GO:0003743 | translation initiation factor activity | 8.72e-02 | 1.00e+00 | 3.459 | 1 | 8 | 37 |
GO:0006281 | DNA repair | 8.81e-02 | 1.00e+00 | 2.003 | 2 | 24 | 203 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 8.94e-02 | 1.00e+00 | 3.421 | 1 | 4 | 38 |
GO:0048511 | rhythmic process | 8.94e-02 | 1.00e+00 | 3.421 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 4 | 40 |
GO:0005840 | ribosome | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 2 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 6 | 40 |
GO:0003684 | damaged DNA binding | 9.62e-02 | 1.00e+00 | 3.311 | 1 | 1 | 41 |
GO:0009612 | response to mechanical stimulus | 1.07e-01 | 1.00e+00 | 3.145 | 1 | 2 | 46 |
GO:0032481 | positive regulation of type I interferon production | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 3 | 48 |
GO:0005777 | peroxisome | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 2 | 50 |
GO:0006334 | nucleosome assembly | 1.18e-01 | 1.00e+00 | 2.996 | 1 | 4 | 51 |
GO:0006289 | nucleotide-excision repair | 1.23e-01 | 1.00e+00 | 2.941 | 1 | 6 | 53 |
GO:0006338 | chromatin remodeling | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 7 | 55 |
GO:0016311 | dephosphorylation | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 1.31e-01 | 1.00e+00 | 2.836 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.33e-01 | 1.00e+00 | 2.810 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.36e-01 | 1.00e+00 | 2.786 | 1 | 6 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 1.40e-01 | 1.00e+00 | 2.738 | 1 | 4 | 61 |
GO:0030018 | Z disc | 1.46e-01 | 1.00e+00 | 2.668 | 1 | 3 | 64 |
GO:0030308 | negative regulation of cell growth | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 5 | 70 |
GO:0071456 | cellular response to hypoxia | 1.71e-01 | 1.00e+00 | 2.421 | 1 | 2 | 76 |
GO:0055114 | oxidation-reduction process | 1.74e-01 | 1.00e+00 | 1.402 | 2 | 9 | 308 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.82e-01 | 1.00e+00 | 1.360 | 2 | 17 | 317 |
GO:0046872 | metal ion binding | 1.92e-01 | 1.00e+00 | 0.801 | 4 | 24 | 934 |
GO:0044255 | cellular lipid metabolic process | 1.97e-01 | 1.00e+00 | 2.193 | 1 | 2 | 89 |
GO:0005506 | iron ion binding | 2.03e-01 | 1.00e+00 | 2.145 | 1 | 4 | 92 |
GO:0000209 | protein polyubiquitination | 2.03e-01 | 1.00e+00 | 2.145 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.03e-01 | 1.00e+00 | 2.145 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 2.07e-01 | 1.00e+00 | 2.114 | 1 | 9 | 94 |
GO:0006457 | protein folding | 2.13e-01 | 1.00e+00 | 2.069 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 2.17e-01 | 1.00e+00 | 2.039 | 1 | 6 | 99 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.29e-01 | 1.00e+00 | 1.954 | 1 | 5 | 105 |
GO:0005783 | endoplasmic reticulum | 2.40e-01 | 1.00e+00 | 1.095 | 2 | 12 | 381 |
GO:0042981 | regulation of apoptotic process | 2.42e-01 | 1.00e+00 | 1.861 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.44e-01 | 1.00e+00 | 1.848 | 1 | 6 | 113 |
GO:0007049 | cell cycle | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 8 | 115 |
GO:0005634 | nucleus | 2.50e-01 | 1.00e+00 | 0.326 | 10 | 158 | 3246 |
GO:0003924 | GTPase activity | 2.55e-01 | 1.00e+00 | 1.774 | 1 | 7 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 2.59e-01 | 1.00e+00 | 1.750 | 1 | 11 | 121 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.66e-01 | 1.00e+00 | 1.703 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 2.75e-01 | 1.00e+00 | 1.646 | 1 | 7 | 130 |
GO:0044212 | transcription regulatory region DNA binding | 2.98e-01 | 1.00e+00 | 1.509 | 1 | 13 | 143 |
GO:0005622 | intracellular | 3.02e-01 | 1.00e+00 | 1.489 | 1 | 2 | 145 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.10e-01 | 1.00e+00 | 0.836 | 2 | 29 | 456 |
GO:0001701 | in utero embryonic development | 3.17e-01 | 1.00e+00 | 1.402 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.29e-01 | 1.00e+00 | 1.338 | 1 | 18 | 161 |
GO:0005874 | microtubule | 3.33e-01 | 1.00e+00 | 1.320 | 1 | 10 | 163 |
GO:0005730 | nucleolus | 3.50e-01 | 1.00e+00 | 0.419 | 4 | 74 | 1217 |
GO:0000166 | nucleotide binding | 3.54e-01 | 1.00e+00 | 1.209 | 1 | 13 | 176 |
GO:0016567 | protein ubiquitination | 3.73e-01 | 1.00e+00 | 1.114 | 1 | 14 | 188 |
GO:0005524 | ATP binding | 3.78e-01 | 1.00e+00 | 0.453 | 3 | 37 | 892 |
GO:0005743 | mitochondrial inner membrane | 3.87e-01 | 1.00e+00 | 1.046 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 3.87e-01 | 1.00e+00 | 1.046 | 1 | 12 | 197 |
GO:0030154 | cell differentiation | 3.98e-01 | 1.00e+00 | 0.996 | 1 | 5 | 204 |
GO:0019899 | enzyme binding | 4.07e-01 | 1.00e+00 | 0.954 | 1 | 7 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 4.19e-01 | 1.00e+00 | 0.900 | 1 | 8 | 218 |
GO:0003682 | chromatin binding | 4.66e-01 | 1.00e+00 | 0.691 | 1 | 15 | 252 |
GO:0006508 | proteolysis | 4.82e-01 | 1.00e+00 | 0.624 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 4.99e-01 | 1.00e+00 | 0.555 | 1 | 11 | 277 |
GO:0006355 | regulation of transcription, DNA-templated | 5.33e-01 | 1.00e+00 | 0.187 | 2 | 31 | 715 |
GO:0008270 | zinc ion binding | 5.43e-01 | 1.00e+00 | 0.163 | 2 | 39 | 727 |
GO:0000278 | mitotic cell cycle | 5.44e-01 | 1.00e+00 | 0.374 | 1 | 28 | 314 |
GO:0016020 | membrane | 5.84e-01 | 1.00e+00 | 0.016 | 3 | 56 | 1207 |
GO:0005509 | calcium ion binding | 5.85e-01 | 1.00e+00 | 0.213 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 5.88e-01 | 1.00e+00 | 0.201 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 6.12e-01 | 1.00e+00 | 0.110 | 1 | 21 | 377 |
GO:0044281 | small molecule metabolic process | 6.27e-01 | 1.00e+00 | -0.053 | 2 | 35 | 844 |
GO:0042803 | protein homodimerization activity | 6.59e-01 | 1.00e+00 | -0.073 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 6.80e-01 | 1.00e+00 | -0.152 | 1 | 12 | 452 |
GO:0005887 | integral component of plasma membrane | 7.67e-01 | 1.00e+00 | -0.499 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 7.92e-01 | 1.00e+00 | -0.603 | 1 | 24 | 618 |
GO:0003677 | DNA binding | 9.14e-01 | 1.00e+00 | -1.219 | 1 | 52 | 947 |
GO:0070062 | extracellular vesicular exosome | 9.30e-01 | 1.00e+00 | -1.012 | 2 | 51 | 1641 |
GO:0006351 | transcription, DNA-templated | 9.40e-01 | 1.00e+00 | -1.403 | 1 | 47 | 1076 |
GO:0005886 | plasma membrane | 9.92e-01 | 1.00e+00 | -2.132 | 1 | 46 | 1784 |